Categories
FDA: COVID-19 regulatory update
- The FDA has made available in its webpage the Fraudulent Coronavirus Disease 2019 (COVID-19) Products
- The FDA issued an Emergency Use Authorization (EUA) to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile to be distributed and used for certain hospitalized patients with COVID-19
- FDA expedites review of diagnostic tests to combat COVID-19
- FDA update on EUA for diagnostic tests
- 3D Printing of Medical Devices, Accessories, Components, and Parts During the COVID-19 Pandemic
